Author: OurCrowd

[Omnix Medical in GlobeNewswire] Omnix Medical secures $25 million in Series C funding co-led by Harel Insurance & Finance and the EIC Fund

JERUSALEM, Israel, October 15, 2025 — Omnix Medical, a biopharmaceutical company developing next-generation anti-infectives for the treatment of life-threatening infections, announced today that it raised $25 million in a Series C funding round co-led by Harel Insurance & Finance and the EIC Fund. Existing shareholders Entree Capital, Tal Ventures, Xenia Ventures, and Oriella Limited demonstrated strong confidence in Omnix’s approach by taking part in the round alongside new external investors, including Prevail Partners and OurCrowd. Read...

Read More

[BioCatch in BioCatch] Banking scams up 65% globally in last year

NEW YORK (Oct. 15, 2025) — A new report from BioCatch, which prevents financial crime by recognizing patterns in human behavior, points to the explosive and exponential growth of scams all around the world. The research pulls data from financial institutions serving nearly 350 million consumers on five different continents and finds scam attempts increased by 65% in the last year. That includes a 100% spike in voice phishing (vishing) scam attempts, a 63% uptick in attempted romance scams, and a 42% increase in attempted investment scams. SMS text-based phishing attacks also rose by a factor of 10. Read more on Reuters...

Read More